HEALTHSOUTH Corp. HSRPP Company Overview Stock Message

New Post Public Reply Private Reply Replies (0) Message Board

Sep 4, 2013 at 6:27 PM

HEALTHSOUTH Corp. HSRPP Company Overview

Stock Message Board http://investorshangout.com/search?q=HSRPP&am...mp;yt1=Go!

HEALTHSOUTH Corp. HSRPP Current Price and Quotes
1,251.25
Previous Close
1,240.00
Open
1,251.25

Daily Range
1,251.25 - 1,251.25
52wk Range
1,310.00 - 1,008.00

Volume
20
Dividend
65.00

Average Vol (3m)
1,977
Yield
5.1948

HEALTHSOUTH Corp. HSRPP
Company Information
3660 Grandview Parkway
Suite 200
Birmingham, AL 35243

Website: http://www.healthsouth.com
Phone: 205-967-7116

HEALTHSOUTH Corp. HSRPP
HEALTHSOUTH Corp. HSRPP
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0000785161
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8060 - Services-Hospitals
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Jay Grinney President, CEO
Mike Snow COO
Gregory L. Doody Secretary
Douglas E. Coltharp EVP, CFO
John P. Whittington EVP, General Counsel, Secretary
Edmund Fay Senior VP, Treasurer
Andy Price Chief Accounting Officer
Company Directors
Not Available
Company Notes
Formerly=Healthsouth Rehabilitation Corp. until 12-94
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

HEALTHSOUTH Corp. HSRPP
HSRPP Security Details Other Company Securities
Share Structure
Market Value1 $496,000,000 a/o Sep 03, 2013
Shares Outstanding 400,000 a/o Dec 31, 2008
Float Not Available
Authorized Shares Not Available
Par Value 1000
Shareholders
Shareholders of Record 9,817 a/o Feb 19, 2013
Corporate Actions
Ex. Date Record Date Pay Date
Dividend (16.25) Jun 27, 2013 Jul 01, 2013 Jul 15, 2013
Dividend (16.25) Mar 27, 2013 Apr 01, 2013 Apr 15, 2013
Dividend (16.25) Dec 28, 2012 Jan 02, 2013 Jan 15, 2013
Short Selling Data
Short Interest 3,625 (2,754.33%)
Aug 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Mellon Investor Services

HEALTHSOUTH Corp. HSRPP Recent News

Sept 3, 2013 OTC Daily Alert Stock Watch - HealthSouth Corporation (NYSE: HLS)
Aug 26, 2013 HealthSouth To Present At Investor Conferences In September
Aug 21, 2013 Hill-Rom to Participate in the Morgan Stanley Global Healthcare Conference
Jul 29, 2013 Five Star Equities Issues New Research Reports on HLS, MCK, PSO and VRSN
Jul 26, 2013 HealthSouth Reports Strong Results for Second Quarter 2013 and Raises Full-Year Guidance
Jul 25, 2013 Hill-Rom Reports Fiscal Third Quarter Adjusted Earnings Per Share In Line With Guidance; Provides Fourth Quarter And Updated Full-year Financial Outlook
Jul 23, 2013 Quarterly and Full-Year Guidance Reaffirmed, Management Changes, Semi-Annual Dividends, and Conference Call Schedules - Research Report on Thoratec, Hill-Rom, Teleflex, Cooper, and ICU Medical
Jul 18, 2013 Quest Diagnostics Names Mark J. Guinan as New CFO
Jul 18, 2013 Hill-Rom Announces Preliminary Fiscal 2013 Third Quarter Results and Search for New CFO; Adjusted Earnings Per Share Expected to be in Line with Guidance
Jun 27, 2013 Hill-Rom Holdings, Inc. Hosts Fiscal 2013 Third Quarter Earnings Conference Call and Webcast

12next >

HEALTHSOUTH Corp. HSRPP Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 2,134,900 2,005,900 1,861,200 1,784,900
Cost of Revenue 151,000 151,200 144,300 141,700
Gross Profit 1,983,900 1,854,700 1,716,900 1,643,200
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 1,468,400 1,368,500 1,299,900 1,275,300
Non-Recurring Items 16,100 21,000 17,200 39,500
Other 82,500 78,800 73,100 67,600
Operating Income 416,900 386,400 326,700 260,800
Income From Continuing Operations
Add'l Income/Expense Items 4,500 (36,100) (21,300) (32,200)
Earnings Before Interest and Tax 434,100 362,300 315,500 233,200
Interest Expense 94,100 119,400 125,600 125,700
Earnings Before Tax 340,000 242,900 189,900 107,500
Income Tax 108,600 37,100 (740,800) (2,900)
Minority Interest 50,900 45,900 40,800 34,000
Equity Earnings Unconsolidated Subsidiary 12,700 12,000 10,100 4,600
Net Income Cont. Operations 231,400 205,800 930,700 110,400
Non Recurring Events
Discontinued Operations 4,500 48,800 9,100 18,400
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 185,000 208,700 899,000 94,800
Preferred Stock and Other Adjustments (24,700) (26,000) (26,000) (26,000)
Net Income Applicable to Common Shareholders 160,300 182,700 873,000 68,800

HSRPP HEALTHSOUTH Corp. Research DD Guide

HSRPP HEALTHSOUTH Corp. Stock Message Board http://investorshangout.com/search?q=HSRPP&am...mp;yt0=Go!
HSRPP HEALTHSOUTH Corp. Stock Quote http://www.otcmarkets.com/stock/HSRPP/quote
HSRPP HEALTHSOUTH Corp. Stock Chart http://www.otcmarkets.com/stock/HSRPP/chart
HSRPP HEALTHSOUTH Corp. Company Info http://www.otcmarkets.com/stock/HSRPP/company-info
HSRPP HEALTHSOUTH Corp. Recent News http://www.otcmarkets.com/stock/HSRPP/news
HSRPP HEALTHSOUTH Corp. Financials http://www.otcmarkets.com/stock/HSRPP/financials
HSRPP HEALTHSOUTH Corp. Filings and Disclosure http://www.otcmarkets.com/stock/HSRPP/filings
HSRPP HEALTHSOUTH Corp. Short Sales http://www.otcmarkets.com/stock/HSRPP/short-sales
HSRPP HEALTHSOUTH Corp. Insider Disclosure http://www.otcmarkets.com/stock/HSRPP/insider-transactions
HSRPP HEALTHSOUTH Corp. Research Reports http://www.otcmarkets.com/stock/HSRPP/research
HSRPP HEALTHSOUTH Corp. Summary http://finance.yahoo.com/q?s=HSRPP
HSRPP HEALTHSOUTH Corp. Historical Prices http://finance.yahoo.com/q/hp?s=HSRPP+Historical+Prices
HSRPP HEALTHSOUTH Corp. Interactive Chart http://finance.yahoo.com/echarts?s=HSRPP
HSRPP HEALTHSOUTH Corp. Basic Chart http://finance.yahoo.com/q/bc?s=HSRPP+Basic+Chart
HSRPP HEALTHSOUTH Corp. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=HSRPP+Basic+Tech.+Analysis
HSRPP HEALTHSOUTH Corp. Headlines http://finance.yahoo.com/q/h?s=HSRPP+Headlines
HSRPP HEALTHSOUTH Corp. Press Releases http://finance.yahoo.com/q/p?s=HSRPP+Press+Releases
HSRPP HEALTHSOUTH Corp. Company Profile http://finance.yahoo.com/q/pr?s=HSRPP+Profile
HSRPP HEALTHSOUTH Corp. Key Statistics http://finance.yahoo.com/q/ks?s=HSRPP+Key+Statistics
HSRPP HEALTHSOUTH Corp. Industry http://finance.yahoo.com/q/in?s=HSRPP+Industry
HSRPP HEALTHSOUTH Corp. Major Holders http://finance.yahoo.com/q/mh?s=HSRPP+Major+Holders
HSRPP HEALTHSOUTH Corp. Insider Transactions http://finance.yahoo.com/q/it?s=HSRPP+Insider+Transactions
HSRPP HEALTHSOUTH Corp. Insider Roster http://finance.yahoo.com/q/ir?s=HSRPP+Insider+Roster
HSRPP HEALTHSOUTH Corp. Income Statement http://finance.yahoo.com/q/is?s=HSRPP
HSRPP HEALTHSOUTH Corp. Balance Sheet http://finance.yahoo.com/q/bs?s=HSRPP
HSRPP HEALTHSOUTH Corp. Cash Flow http://finance.yahoo.com/q/cf?s=HSRPP+Cash+Flow&annual
HSRPP HEALTHSOUTH Corp. Nasdaq http://www.nasdaq.com/symbol/HSRPP
HSRPP HEALTHSOUTH Corp. Market Watch http://www.marketwatch.com/investing/stock/HSRPP
HSRPP HEALTHSOUTH Corp. Bloomberg http://www.bloomberg.com/quote/HSRPP:US
HSRPP HEALTHSOUTH Corp. Morningstar http://quotes.morningstar.com/stock/s?t=HSRPP
HSRPP HEALTHSOUTH Corp. Bussinessweek http://investing.businessweek.com/research/st...cker=HSRPP
HSRPP HEALTHSOUTH Corp. Barchart http://www.barchart.com/quotes/stocks/HSRPP
HSRPP HEALTHSOUTH Corp. OTC Short Report http://otcshortreport.com/index.php?index=HSRPP
HSRPP HEALTHSOUTH Corp. Investopedia http://www.investopedia.com/markets/stocks/HSRPP/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...